This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Artman, M. Articles by Graham, T. P. Search for Related Content PubMed PubMed Citation Articles by Artman, M. Articles by Graham, T. P., Jr

Circulation, Vol 69, 949-954, Copyright © 1984 by American Heart Association

ARTICLES

Short-term hemodynamic effects of hydralazine in infants with complete atrioventricular canal defects

M Artman, MD Parrish, RC Boerth, RJ Boucek Jr and TP Graham Jr

We evaluated the acute hemodynamic responses to hydralazine during cardiac catheterization in eight infants (ages 1.0 to 5.5 months) with congestive heart failure due to complete atrioventricular canal defect. Hydralazine administered intravenously (0.5 to 1.0 mg/kg body weight) increased heart rate and systemic blood flow and decreased mean right atrial pressure, systemic and pulmonic arterial pressures, systemic arteriolar resistance, and the ratio of pulmonary to systemic blood flow (p less than .05). The percentage of pulmonary flow contributed by shunted blood (percent left-to-right shunt; measured by indicator dilution) was decreased by hydralazine in six (mean = 85% before to 64% after hydralazine; p less than .01), but remained unchanged (79%) in two infants. The two infants with no change in percent left-to-right shunt had higher pulmonary arteriolar resistances (Rp) before hydralazine (mean = 12.8 vs 3.2 U/m2) and had greater declines in Rp (mean change = -5.1 vs + 0.3 U/m2) in response to hydralazine. Thus, if Rp does not fall, hydralazine reduces the percentage of left-to-right shunt over the short term and therefore might be useful for managing congestive heart failure in these infants. However, because the response varies, an evaluation of the short-term hemodynamic effects of hydralazine may be warranted in an attempt to select those infants who might respond favorably to long-term hydralazine therapy.

This article has been cited by other articles:

				D. Journois, P. Pouard, P. Mauriat, T. Malhere, P. Vouhe, and D. Safran Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects J. Thorac. Cardiovasc. Surg., April 1, 1994; 107(4): 1129 - 1135. [Abstract] [Full Text]

				R. E. Shaddy, D. F. Teitel, and C. Brett Short-term Hemodynamic Effects of Captopril in Infants With Congestive Heart Failure Arch Pediatr Adolesc Med, January 1, 1988; 142(1): 100 - 105. [Abstract] [PDF]